These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 21904603)
21. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer. Wang Q; Imam MU; Yida Z; Wang F Curr Pharm Des; 2017; 23(25):3677-3688. PubMed ID: 28677503 [TBL] [Abstract][Full Text] [Related]
22. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs. Puhl AC; Milton FA; Cvoro A; Sieglaff DH; Campos JC; Bernardes A; Filgueira CS; Lindemann JL; Deng T; Neves FA; Polikarpov I; Webb P Nucl Recept Signal; 2015; 13():e004. PubMed ID: 26445566 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) γ partial agonists. Kaserer T; Obermoser V; Weninger A; Gust R; Schuster D Eur J Med Chem; 2016 Nov; 124():49-62. PubMed ID: 27560282 [TBL] [Abstract][Full Text] [Related]
24. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation. Wang X; Sun Y; Zhao Y; Ding Y; Zhang X; Kong L; Li Z; Guo Q; Zhao L Biochem Pharmacol; 2016 Apr; 106():70-81. PubMed ID: 26947454 [TBL] [Abstract][Full Text] [Related]
25. Identification and Characterization of Cannabimovone, a Cannabinoid from Iannotti FA; De Maio F; Panza E; Appendino G; Taglialatela-Scafati O; De Petrocellis L; Amodeo P; Vitale RM Molecules; 2020 Mar; 25(5):. PubMed ID: 32138197 [TBL] [Abstract][Full Text] [Related]
26. Sulfonylthiadiazoles with an unusual binding mode as partial dual peroxisome proliferator-activated receptor (PPAR) γ/δ agonists with high potency and in vivo efficacy. Keil S; Matter H; Schönafinger K; Glien M; Mathieu M; Marquette JP; Michot N; Haag-Diergarten S; Urmann M; Wendler W ChemMedChem; 2011 Apr; 6(4):633-53. PubMed ID: 21400663 [TBL] [Abstract][Full Text] [Related]
27. Computational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2. Lu P; Hontecillas R; Horne WT; Carbo A; Viladomiu M; Pedragosa M; Bevan DR; Lewis SN; Bassaganya-Riera J PLoS One; 2012; 7(4):e34643. PubMed ID: 22509338 [TBL] [Abstract][Full Text] [Related]
32. Identification of dual PPARα/γ agonists and their effects on lipid metabolism. Gao Q; Hanh J; Váradi L; Cairns R; Sjöström H; Liao VW; Wood P; Balaban S; Ong JA; Lin HY; Lai F; Hoy AJ; Grewal T; Groundwater PW; Hibbs DE Bioorg Med Chem; 2015 Dec; 23(24):7676-84. PubMed ID: 26616289 [TBL] [Abstract][Full Text] [Related]
33. Identification of PPARgamma partial agonists of natural origin (I): development of a virtual screening procedure and in vitro validation. Guasch L; Sala E; Castell-Auví A; Cedó L; Liedl KR; Wolber G; Muehlbacher M; Mulero M; Pinent M; Ardévol A; Valls C; Pujadas G; Garcia-Vallvé S PLoS One; 2012; 7(11):e50816. PubMed ID: 23226391 [TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor gamma in the colon: inflammation and innate antimicrobial immunity. Speca S; Dubuquoy L; Desreumaux P J Clin Gastroenterol; 2014; 48 Suppl 1():S23-7. PubMed ID: 25291120 [TBL] [Abstract][Full Text] [Related]
35. Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and PPARγ. Caioni G; Viscido A; d'Angelo M; Panella G; Castelli V; Merola C; Frieri G; Latella G; Cimini A; Benedetti E Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498177 [TBL] [Abstract][Full Text] [Related]
36. Novel PPARγ partial agonists with weak activity and no cytotoxicity; identified by a simple PPARγ ligand screening system. Cho MC; Lee DH; Kim EJ; Lee JY; Kang JW; Song JH; Chong Y; Kim Y; Hong JT; Yoon DY Mol Cell Biochem; 2011 Dec; 358(1-2):75-83. PubMed ID: 21681413 [TBL] [Abstract][Full Text] [Related]
37. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model. Nakano Y; Arima T; Tobita Y; Uchiyama M; Shimizu A; Takahashi H Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707656 [TBL] [Abstract][Full Text] [Related]
39. Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes. Pang T; Benicky J; Wang J; Orecna M; Sanchez-Lemus E; Saavedra JM J Hypertens; 2012 Jan; 30(1):87-96. PubMed ID: 22124178 [TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach. D'Aniello E; Fellous T; Iannotti FA; Gentile A; Allarà M; Balestrieri F; Gray R; Amodeo P; Vitale RM; Di Marzo V Biochim Biophys Acta Gen Subj; 2019 Mar; 1863(3):586-597. PubMed ID: 30611848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]